Suprachoroidal Triamcinolone Injection in Posterior Scleritis: A Case Report

ABSTRACT

Suprachoroidal triamcinolone acetonide (SCS-TA) injections were recently approved to treat macular edema secondary to noninfectious uveitis. However, its use in managing posterior scleritis has not been reported. We report the first case of SCS-TA used in the treatment of posterior scleritis. A 67-year-old woman with posterior scleritis complicated by exudative retinal detachment, diagnosed by spectral-domain optical coherence tomography scan (OCT), presented with pain, decreased vision, and redness in the left eye for 8 months. She was previously prescribed topical prednisolone and oral prednisone with minimal improvement. She also had a history of rheumatoid arthritis treated with multiple systemic immunosuppressive agents. After SCS-TA, the patient’s pain resolved and visual acuity improved. OCT demonstrated significant reduction in sclerochoroidal thickening. Via its novel delivery method, SCS-TA may be an effective treatment for posterior scleritis. Further studies are needed to establish long-term efficacy and safety of this treatment modality.

KEYWORDS:

• Ocular inflammation
• posterior scleritis
• suprachoroidal triamcinolone injection
• uveitis

Disclosure statement

Peter Y Chang is a consultant for Bausch and Lomb, which is relevant to the research reported in the enclosed paper. However, there was no financial support in producing this work and we have an approved plan for managing any potential conflicts arising from that involvement. Ploysai Rujkorakarn, Avery Zhou, & Fatima Babiker report no competing interests to declare.

Statement of consent

This patient has given informed consent to participate in the research.

Additional information

Funding

The authors received no financial support for this work.